Thoratec Says Lead Failure Update Will Not Slow HeartMate II Momentum
This article was originally published in The Gray Sheet
Executive Summary
New warnings about potential percutaneous lead failures on Thoratec's HeartMate II ventricular assist device will not slow its rapid market adoption, the company predicts
You may also be interested in...
Thoratec's HeartMate II Implant Boosts Stroke-Free Survival Four-Fold - Study
Thoratec's next-generation HeartMate II continuous-flow left ventricular assist device enables a more than four-fold increase in two-year survival rate free from stroke and reoperation compared with the firm's HeartMate XVE pulsatile-flow LVAD, according to study data unveiled Nov. 17
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.